ArticlePharmaceuticals (Basel, Switzerland)2023

A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities.

Mohadeseh Namjoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.